Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

FOSUN PHARMA(02196.HK)

Event Tracking

Apr1

Fosun Pharma's Subsidiary Obtains Approval for HLX319 Phase I Clinical Trials for Breast Cancer

08:58

Establishment of Tianjin Fosun Haihe Healthcare Industry Fund Phase II

07:42

Mar31

Fosun Pharma's Subsidiaries Receive Approval for Two Drug Clinical Trials

09:30

Mar24

Fosun Pharmaceutical's JediVision Receives Market Release Approval, Plans to Launch in June 2025

13:14

Fosun Pharma reports a 21.69% YoY increase in net profit in 2025

10:36

FOSUN PHARMA released FY2025 Q4 earnings on March 24 During-Market (BJT), actual revenue HKD 13.64 B (forecast HKD 10.91 B), actual EPS HKD 0.3558 (forecast HKD 0.3263)

08:00

Schedules & Filings

Schedules

Filings

Apr29

Earning Release(CST)

FY2026 Q1 Earning Release

Mar24

Earning Release(CST)

FY2025 Q4 Earning Release (HKD) Revenue 13.64 B, Net Income 942.19 M, EPS 0.3558

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 10.8 B, Net Income 897.85 M, EPS 0.3388

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

FOSUN PHARMA(02196.HK)

FOSUN PHARMA Stock Performance Chart

Trending